Thirumalai Chemicals Limited

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ASIANPAINT.BO has a market cap of 2.5T. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ASIANPAINT.BO trades at ₹2,600.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ASIANPAINT.BO's P/E ratio is 64.62. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ASIANPAINT.BO's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to ASIANPAINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ASIANPAINT.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ASIANPAINT.NS has a market cap of 2.5T. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ASIANPAINT.NS trades at ₹2,595.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ASIANPAINT.NS's P/E ratio is 64.98. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ASIANPAINT.NS's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to ASIANPAINT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ASIANPAINT.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, SOLARINDS.NS has a market cap of 1.6T. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while SOLARINDS.NS trades at ₹18,388.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas SOLARINDS.NS's P/E ratio is 98.55. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to SOLARINDS.NS's ROE of +0.33%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to SOLARINDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check SOLARINDS.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, SOLARINDS.BO has a market cap of 1.6T. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while SOLARINDS.BO trades at ₹18,390.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas SOLARINDS.BO's P/E ratio is 98.62. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to SOLARINDS.BO's ROE of +0.33%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to SOLARINDS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check SOLARINDS.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, PIDILITIND.NS has a market cap of 1.5T. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while PIDILITIND.NS trades at ₹1,472.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas PIDILITIND.NS's P/E ratio is 60.47. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to PIDILITIND.NS's ROE of +0.24%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to PIDILITIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check PIDILITIND.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, PIDILITIND.BO has a market cap of 1.5T. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while PIDILITIND.BO trades at ₹1,473.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas PIDILITIND.BO's P/E ratio is 64.74. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to PIDILITIND.BO's ROE of +0.24%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to PIDILITIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check PIDILITIND.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, SRF.NS has a market cap of 774.6B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while SRF.NS trades at ₹2,619.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas SRF.NS's P/E ratio is 42.17. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to SRF.NS's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to SRF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check SRF.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, SRF.BO has a market cap of 774.6B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while SRF.BO trades at ₹2,620.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas SRF.BO's P/E ratio is 42.19. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to SRF.BO's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to SRF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check SRF.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, LINDEINDIA.NS has a market cap of 618.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while LINDEINDIA.NS trades at ₹7,273.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas LINDEINDIA.NS's P/E ratio is 104.68. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to LINDEINDIA.NS's ROE of +0.16%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to LINDEINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check LINDEINDIA.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, LINDEINDIA.BO has a market cap of 618.5B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while LINDEINDIA.BO trades at ₹7,265.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas LINDEINDIA.BO's P/E ratio is 105.16. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to LINDEINDIA.BO's ROE of +0.16%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to LINDEINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check LINDEINDIA.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, BERGEPAINT.NS has a market cap of 592.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while BERGEPAINT.NS trades at ₹499.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas BERGEPAINT.NS's P/E ratio is 52.69. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to BERGEPAINT.NS's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to BERGEPAINT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check BERGEPAINT.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, BERGEPAINT.BO has a market cap of 592.4B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while BERGEPAINT.BO trades at ₹500.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas BERGEPAINT.BO's P/E ratio is 54.81. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to BERGEPAINT.BO's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to BERGEPAINT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check BERGEPAINT.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, FLUOROCHEM.NS has a market cap of 412B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while FLUOROCHEM.NS trades at ₹3,824.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas FLUOROCHEM.NS's P/E ratio is 62.94. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to FLUOROCHEM.NS's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to FLUOROCHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check FLUOROCHEM.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, FLUOROCHEM.BO has a market cap of 412B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while FLUOROCHEM.BO trades at ₹3,835.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas FLUOROCHEM.BO's P/E ratio is 62.90. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to FLUOROCHEM.BO's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to FLUOROCHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check FLUOROCHEM.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, HSCL.BO has a market cap of 293.7B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while HSCL.BO trades at ₹588.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas HSCL.BO's P/E ratio is 38.81. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to HSCL.BO's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to HSCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check HSCL.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, HSCL.NS has a market cap of 293.3B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while HSCL.NS trades at ₹590.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas HSCL.NS's P/E ratio is 38.76. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to HSCL.NS's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to HSCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check HSCL.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ACUTAAS.BO has a market cap of 236.2B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ACUTAAS.BO trades at ₹3,009.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ACUTAAS.BO's P/E ratio is 82.66. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ACUTAAS.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to ACUTAAS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ACUTAAS.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ACUTAAS.NS has a market cap of 235.8B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ACUTAAS.NS trades at ₹2,999.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ACUTAAS.NS's P/E ratio is 82.40. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ACUTAAS.NS's ROE of +0.24%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to ACUTAAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ACUTAAS.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ATUL.NS has a market cap of 205.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ATUL.NS trades at ₹7,043.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ATUL.NS's P/E ratio is 30.33. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ATUL.NS's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to ATUL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ATUL.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ATUL.BO has a market cap of 205.6B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ATUL.BO trades at ₹7,051.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ATUL.BO's P/E ratio is 34.61. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ATUL.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to ATUL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ATUL.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, KANSAINER.NS has a market cap of 173.5B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while KANSAINER.NS trades at ₹217.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas KANSAINER.NS's P/E ratio is 29.52. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to KANSAINER.NS's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to KANSAINER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check KANSAINER.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, KANSAINER.BO has a market cap of 173.5B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while KANSAINER.BO trades at ₹217.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas KANSAINER.BO's P/E ratio is 29.63. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to KANSAINER.BO's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to KANSAINER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check KANSAINER.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, DCMSHRIRAM.NS has a market cap of 171.2B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while DCMSHRIRAM.NS trades at ₹1,110.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas DCMSHRIRAM.NS's P/E ratio is 20.05. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to DCMSHRIRAM.NS's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to DCMSHRIRAM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check DCMSHRIRAM.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, DCMSHRIRAM.BO has a market cap of 170.7B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while DCMSHRIRAM.BO trades at ₹1,109.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas DCMSHRIRAM.BO's P/E ratio is 20.00. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to DCMSHRIRAM.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to DCMSHRIRAM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check DCMSHRIRAM.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, AARTIIND.BO has a market cap of 168.2B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while AARTIIND.BO trades at ₹482.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas AARTIIND.BO's P/E ratio is 44.57. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to AARTIIND.BO's ROE of +0.07%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to AARTIIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check AARTIIND.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, AARTIIND.NS has a market cap of 168B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while AARTIIND.NS trades at ₹482.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas AARTIIND.NS's P/E ratio is 40.08. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to AARTIIND.NS's ROE of +0.07%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to AARTIIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check AARTIIND.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, BASF.BO has a market cap of 157B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while BASF.BO trades at ₹3,585.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas BASF.BO's P/E ratio is 41.80. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to BASF.BO's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to BASF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check BASF.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, BASF.NS has a market cap of 156.8B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while BASF.NS trades at ₹3,582.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas BASF.NS's P/E ratio is 37.59. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to BASF.NS's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to BASF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check BASF.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ANURAS.BO has a market cap of 156.4B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ANURAS.BO trades at ₹1,374.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ANURAS.BO's P/E ratio is 89.26. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ANURAS.BO's ROE of +0.06%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to ANURAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ANURAS.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ANURAS.NS has a market cap of 156.1B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ANURAS.NS trades at ₹1,374.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ANURAS.NS's P/E ratio is 89.17. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ANURAS.NS's ROE of +0.06%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to ANURAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ANURAS.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, AETHER.BO has a market cap of 144.1B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while AETHER.BO trades at ₹1,080.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas AETHER.BO's P/E ratio is 65.71. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to AETHER.BO's ROE of +0.10%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to AETHER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check AETHER.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, AETHER.NS has a market cap of 144.1B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while AETHER.NS trades at ₹1,082.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas AETHER.NS's P/E ratio is 65.59. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to AETHER.NS's ROE of +0.10%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to AETHER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check AETHER.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, FINEORG.NS has a market cap of 140.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while FINEORG.NS trades at ₹4,593.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas FINEORG.NS's P/E ratio is 33.76. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to FINEORG.NS's ROE of +0.17%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to FINEORG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check FINEORG.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, FINEORG.BO has a market cap of 140.7B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while FINEORG.BO trades at ₹4,640.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas FINEORG.BO's P/E ratio is 33.74. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to FINEORG.BO's ROE of +0.17%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to FINEORG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check FINEORG.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, VINATIORGA.BO has a market cap of 137.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while VINATIORGA.BO trades at ₹1,334.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas VINATIORGA.BO's P/E ratio is 31.10. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to VINATIORGA.BO's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to VINATIORGA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check VINATIORGA.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, VINATIORGA.NS has a market cap of 137.8B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while VINATIORGA.NS trades at ₹1,334.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas VINATIORGA.NS's P/E ratio is 31.08. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to VINATIORGA.NS's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to VINATIORGA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check VINATIORGA.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, AKZOINDIA.NS has a market cap of 136B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while AKZOINDIA.NS trades at ₹2,986.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas AKZOINDIA.NS's P/E ratio is 6.95. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to AKZOINDIA.NS's ROE of +1.07%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to AKZOINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check AKZOINDIA.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, AKZOINDIA.BO has a market cap of 136B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while AKZOINDIA.BO trades at ₹2,985.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas AKZOINDIA.BO's P/E ratio is 6.95. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to AKZOINDIA.BO's ROE of +1.07%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to AKZOINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check AKZOINDIA.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, GRWRHITECH.BO has a market cap of 131B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while GRWRHITECH.BO trades at ₹5,540.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas GRWRHITECH.BO's P/E ratio is 38.67. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to GRWRHITECH.BO's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to GRWRHITECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check GRWRHITECH.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, GRWRHITECH.NS has a market cap of 130.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while GRWRHITECH.NS trades at ₹5,516.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas GRWRHITECH.NS's P/E ratio is 38.77. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to GRWRHITECH.NS's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to GRWRHITECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check GRWRHITECH.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, PRIVISCL.BO has a market cap of 124.2B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while PRIVISCL.BO trades at ₹3,267.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas PRIVISCL.BO's P/E ratio is 37.97. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to PRIVISCL.BO's ROE of +0.27%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to PRIVISCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check PRIVISCL.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, PRIVISCL.NS has a market cap of 123.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while PRIVISCL.NS trades at ₹3,268.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas PRIVISCL.NS's P/E ratio is 37.80. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to PRIVISCL.NS's ROE of +0.27%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to PRIVISCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check PRIVISCL.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, JUBLINGREA.BO has a market cap of 116.1B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while JUBLINGREA.BO trades at ₹747.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas JUBLINGREA.BO's P/E ratio is 43.93. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to JUBLINGREA.BO's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to JUBLINGREA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check JUBLINGREA.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, JUBLINGREA.NS has a market cap of 116B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while JUBLINGREA.NS trades at ₹748.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas JUBLINGREA.NS's P/E ratio is 43.83. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to JUBLINGREA.NS's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to JUBLINGREA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check JUBLINGREA.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, PCBL.NS has a market cap of 115.1B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while PCBL.NS trades at ₹290.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas PCBL.NS's P/E ratio is 43.36. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to PCBL.NS's ROE of +0.05%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to PCBL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check PCBL.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, PCBL.BO has a market cap of 115B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while PCBL.BO trades at ₹291.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas PCBL.BO's P/E ratio is 43.30. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to PCBL.BO's ROE of +0.05%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to PCBL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check PCBL.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, AMIORG.NS has a market cap of 96.3B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while AMIORG.NS trades at ₹1,176.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas AMIORG.NS's P/E ratio is 119.06. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to AMIORG.NS's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to AMIORG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check AMIORG.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, AMIORG.BO has a market cap of 96.3B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while AMIORG.BO trades at ₹1,176.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas AMIORG.BO's P/E ratio is 118.95. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to AMIORG.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to AMIORG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check AMIORG.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ALKYLAMINE.BO has a market cap of 90.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ALKYLAMINE.BO trades at ₹1,748.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ALKYLAMINE.BO's P/E ratio is 50.45. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ALKYLAMINE.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to ALKYLAMINE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ALKYLAMINE.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ALKYLAMINE.NS has a market cap of 90.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ALKYLAMINE.NS trades at ₹1,743.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ALKYLAMINE.NS's P/E ratio is 50.56. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ALKYLAMINE.NS's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to ALKYLAMINE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ALKYLAMINE.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, CLEAN.NS has a market cap of 80.2B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while CLEAN.NS trades at ₹760.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas CLEAN.NS's P/E ratio is 34.93. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to CLEAN.NS's ROE of +0.16%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to CLEAN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check CLEAN.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, CLEAN.BO has a market cap of 80.2B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while CLEAN.BO trades at ₹760.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas CLEAN.BO's P/E ratio is 34.89. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to CLEAN.BO's ROE of +0.16%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to CLEAN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check CLEAN.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, KINGFA.NS has a market cap of 70.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while KINGFA.NS trades at ₹5,175.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas KINGFA.NS's P/E ratio is 40.92. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to KINGFA.NS's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to KINGFA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check KINGFA.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, KINGFA.BO has a market cap of 70.8B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while KINGFA.BO trades at ₹5,182.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas KINGFA.BO's P/E ratio is 40.99. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to KINGFA.BO's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to KINGFA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check KINGFA.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, SUDARSCHEM.BO has a market cap of 68B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while SUDARSCHEM.BO trades at ₹954.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas SUDARSCHEM.BO's P/E ratio is 127.91. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to SUDARSCHEM.BO's ROE of -0.02%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to SUDARSCHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check SUDARSCHEM.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, SUDARSCHEM.NS has a market cap of 67.8B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while SUDARSCHEM.NS trades at ₹981.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas SUDARSCHEM.NS's P/E ratio is -109.43. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to SUDARSCHEM.NS's ROE of -0.02%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to SUDARSCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check SUDARSCHEM.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, GALAXYSURF.BO has a market cap of 64.7B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while GALAXYSURF.BO trades at ₹1,818.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas GALAXYSURF.BO's P/E ratio is 24.22. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to GALAXYSURF.BO's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to GALAXYSURF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check GALAXYSURF.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, GALAXYSURF.NS has a market cap of 64.7B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while GALAXYSURF.NS trades at ₹1,828.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas GALAXYSURF.NS's P/E ratio is 24.21. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to GALAXYSURF.NS's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to GALAXYSURF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check GALAXYSURF.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, BALAMINES.NS has a market cap of 59.4B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while BALAMINES.NS trades at ₹1,845.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas BALAMINES.NS's P/E ratio is 41.26. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to BALAMINES.NS's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to BALAMINES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check BALAMINES.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, BALAMINES.BO has a market cap of 59.2B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while BALAMINES.BO trades at ₹1,852.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas BALAMINES.BO's P/E ratio is 41.03. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to BALAMINES.BO's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to BALAMINES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check BALAMINES.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, INDIGOPNTS.NS has a market cap of 46.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while INDIGOPNTS.NS trades at ₹992.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas INDIGOPNTS.NS's P/E ratio is 32.63. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to INDIGOPNTS.NS's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to INDIGOPNTS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check INDIGOPNTS.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, INDIGOPNTS.BO has a market cap of 46.8B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while INDIGOPNTS.BO trades at ₹993.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas INDIGOPNTS.BO's P/E ratio is 32.53. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to INDIGOPNTS.BO's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to INDIGOPNTS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check INDIGOPNTS.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, NEOGEN.BO has a market cap of 44.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while NEOGEN.BO trades at ₹1,685.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas NEOGEN.BO's P/E ratio is 228.35. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to NEOGEN.BO's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to NEOGEN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check NEOGEN.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, NEOGEN.NS has a market cap of 44.7B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while NEOGEN.NS trades at ₹1,684.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas NEOGEN.NS's P/E ratio is 227.92. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to NEOGEN.NS's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to NEOGEN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check NEOGEN.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, GULFOILLUB.NS has a market cap of 44.6B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while GULFOILLUB.NS trades at ₹897.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas GULFOILLUB.NS's P/E ratio is 12.84. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to GULFOILLUB.NS's ROE of +0.23%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to GULFOILLUB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check GULFOILLUB.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, GULFOILLUB.BO has a market cap of 44.6B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while GULFOILLUB.BO trades at ₹898.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas GULFOILLUB.BO's P/E ratio is 12.84. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to GULFOILLUB.BO's ROE of +0.23%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to GULFOILLUB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check GULFOILLUB.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, POCL.NS has a market cap of 44.5B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while POCL.NS trades at ₹1,448.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas POCL.NS's P/E ratio is 39.21. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to POCL.NS's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to POCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check POCL.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, POCL.BO has a market cap of 44.5B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while POCL.BO trades at ₹1,452.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas POCL.BO's P/E ratio is 38.98. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to POCL.BO's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to POCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check POCL.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, LXCHEM.BO has a market cap of 44B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while LXCHEM.BO trades at ₹159.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas LXCHEM.BO's P/E ratio is 55.30. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to LXCHEM.BO's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to LXCHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check LXCHEM.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, LXCHEM.NS has a market cap of 43.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while LXCHEM.NS trades at ₹159.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas LXCHEM.NS's P/E ratio is 55.22. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to LXCHEM.NS's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to LXCHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check LXCHEM.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, RESPONIND.NS has a market cap of 43.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while RESPONIND.NS trades at ₹165.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas RESPONIND.NS's P/E ratio is 24.37. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to RESPONIND.NS's ROE of +0.13%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to RESPONIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check RESPONIND.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, RESPONIND.BO has a market cap of 43.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while RESPONIND.BO trades at ₹166.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas RESPONIND.BO's P/E ratio is 24.37. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to RESPONIND.BO's ROE of +0.13%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to RESPONIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check RESPONIND.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ADVENZYMES.NS has a market cap of 43.5B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ADVENZYMES.NS trades at ₹385.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ADVENZYMES.NS's P/E ratio is 25.81. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ADVENZYMES.NS's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to ADVENZYMES.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ADVENZYMES.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ADVENZYMES.BO has a market cap of 43.4B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ADVENZYMES.BO trades at ₹386.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ADVENZYMES.BO's P/E ratio is 25.79. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ADVENZYMES.BO's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to ADVENZYMES.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ADVENZYMES.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, TANFACIND.BO has a market cap of 42.2B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while TANFACIND.BO trades at ₹2,120.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas TANFACIND.BO's P/E ratio is 59.93. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to TANFACIND.BO's ROE of +0.22%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to TANFACIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check TANFACIND.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, VISHNU.NS has a market cap of 40.4B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while VISHNU.NS trades at ₹597.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas VISHNU.NS's P/E ratio is 29.23. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to VISHNU.NS's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to VISHNU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check VISHNU.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, VISHNU.BO has a market cap of 40.3B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while VISHNU.BO trades at ₹596.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas VISHNU.BO's P/E ratio is 29.19. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to VISHNU.BO's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to VISHNU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check VISHNU.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, JINDALPOLY.BO has a market cap of 30.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while JINDALPOLY.BO trades at ₹694.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas JINDALPOLY.BO's P/E ratio is -23.81. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to JINDALPOLY.BO's ROE of -0.06%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to JINDALPOLY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check JINDALPOLY.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, JINDALPOLY.NS has a market cap of 30.8B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while JINDALPOLY.NS trades at ₹691.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas JINDALPOLY.NS's P/E ratio is -14.52. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to JINDALPOLY.NS's ROE of -0.06%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to JINDALPOLY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check JINDALPOLY.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, PREMEXPLN.BO has a market cap of 29.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while PREMEXPLN.BO trades at ₹574.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas PREMEXPLN.BO's P/E ratio is 69.68. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to PREMEXPLN.BO's ROE of +0.17%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to PREMEXPLN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check PREMEXPLN.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, PREMEXPLN.NS has a market cap of 29.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while PREMEXPLN.NS trades at ₹577.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas PREMEXPLN.NS's P/E ratio is 69.73. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to PREMEXPLN.NS's ROE of +0.17%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to PREMEXPLN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check PREMEXPLN.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, TATVA.BO has a market cap of 29.1B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while TATVA.BO trades at ₹1,194.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas TATVA.BO's P/E ratio is 88.49. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to TATVA.BO's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to TATVA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check TATVA.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, TATVA.NS has a market cap of 29.1B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while TATVA.NS trades at ₹1,187.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas TATVA.NS's P/E ratio is 88.52. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to TATVA.NS's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to TATVA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check TATVA.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, GRAUWEIL.NS has a market cap of 29B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while GRAUWEIL.NS trades at ₹65.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas GRAUWEIL.NS's P/E ratio is 20.66. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to GRAUWEIL.NS's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to GRAUWEIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check GRAUWEIL.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, GRAUWEIL.BO has a market cap of 29B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while GRAUWEIL.BO trades at ₹65.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas GRAUWEIL.BO's P/E ratio is 20.64. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to GRAUWEIL.BO's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to GRAUWEIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check GRAUWEIL.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, SOTL.NS has a market cap of 28.6B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while SOTL.NS trades at ₹421.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas SOTL.NS's P/E ratio is 15.74. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to SOTL.NS's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to SOTL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check SOTL.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, SOTL.BO has a market cap of 28.6B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while SOTL.BO trades at ₹424.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas SOTL.BO's P/E ratio is 15.72. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to SOTL.BO's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to SOTL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check SOTL.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ROSSARI.BO has a market cap of 28.1B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ROSSARI.BO trades at ₹516.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ROSSARI.BO's P/E ratio is 18.84. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ROSSARI.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to ROSSARI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ROSSARI.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, ROSSARI.NS has a market cap of 28.1B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while ROSSARI.NS trades at ₹518.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas ROSSARI.NS's P/E ratio is 18.85. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to ROSSARI.NS's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to ROSSARI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check ROSSARI.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, NOCIL.NS has a market cap of 28B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while NOCIL.NS trades at ₹166.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas NOCIL.NS's P/E ratio is 50.56. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to NOCIL.NS's ROE of +0.03%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to NOCIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check NOCIL.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, NOCIL.BO has a market cap of 28B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while NOCIL.BO trades at ₹165.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas NOCIL.BO's P/E ratio is 44.51. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to NOCIL.BO's ROE of +0.03%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to NOCIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check NOCIL.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, POLYPLEX.NS has a market cap of 27.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while POLYPLEX.NS trades at ₹982.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas POLYPLEX.NS's P/E ratio is 92.37. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to POLYPLEX.NS's ROE of +0.01%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to POLYPLEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check POLYPLEX.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, POLYPLEX.BO has a market cap of 27.9B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while POLYPLEX.BO trades at ₹982.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas POLYPLEX.BO's P/E ratio is 92.23. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to POLYPLEX.BO's ROE of +0.01%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to POLYPLEX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check POLYPLEX.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, JUBLCPL.BO has a market cap of 26.2B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while JUBLCPL.BO trades at ₹1,745.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas JUBLCPL.BO's P/E ratio is 21.59. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to JUBLCPL.BO's ROE of +0.13%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to JUBLCPL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check JUBLCPL.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, APCOTEXIND.BO has a market cap of 26.1B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while APCOTEXIND.BO trades at ₹492.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas APCOTEXIND.BO's P/E ratio is 31.35. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to APCOTEXIND.BO's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to APCOTEXIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check APCOTEXIND.BO's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, APCOTEXIND.NS has a market cap of 26.1B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while APCOTEXIND.NS trades at ₹493.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas APCOTEXIND.NS's P/E ratio is 25.74. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to APCOTEXIND.NS's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to APCOTEXIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check APCOTEXIND.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, JUBLCPL.NS has a market cap of 26B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while JUBLCPL.NS trades at ₹1,750.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas JUBLCPL.NS's P/E ratio is 21.42. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to JUBLCPL.NS's ROE of +0.33%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to JUBLCPL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check JUBLCPL.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, JUBLINDS.NS has a market cap of 25.6B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while JUBLINDS.NS trades at ₹1,633.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas JUBLINDS.NS's P/E ratio is 72.49. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to JUBLINDS.NS's ROE of +0.13%. Regarding short-term risk, TIRUMALCHM.BO is less volatile compared to JUBLINDS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check JUBLINDS.NS's competition here

TIRUMALCHM.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.BO stands at 25.5B. In comparison, TIRUMALCHM.NS has a market cap of 25.6B. Regarding current trading prices, TIRUMALCHM.BO is priced at ₹213.00, while TIRUMALCHM.NS trades at ₹213.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.BO currently has a P/E ratio of -14.78, whereas TIRUMALCHM.NS's P/E ratio is -15.05. In terms of profitability, TIRUMALCHM.BO's ROE is -0.12%, compared to TIRUMALCHM.NS's ROE of -0.12%. Regarding short-term risk, TIRUMALCHM.BO is more volatile compared to TIRUMALCHM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.BO.Check TIRUMALCHM.NS's competition here